tbuckley/cabot-search huggingface dataset:
Early and Sustained Circulating Tumor DNA Response Dynamics after Loncastuximab Tesirine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Authors: David M. Kurtz, Gregory Hogan, Andre Schultz, Jacob J. Chabon, Ash A. Alizadeh, Karin Havenith, Sara Samari, Tim Kopotsha, Luqiang Wang, Yajuan Qin, Ying Wang, Serafino Pantano
Journal: Blood (2023)
Baricitinib in Combination with High-Dose Dexamethasone As First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial
Authors: Peng Zhao, Zhuoyu An, Haixia Fu, Daihong Liu, Liping Dou, Yi Liu, Hui Liu, Zhao Wang, Yujun Dong, Hongmei Jing, Hebing Zhou, Zhen-Ling Li, Lihong Li, Qiu-Sha Huang, Jin Wu, Yejun Wu, Chen-Cong Wang, Xiaolu Zhu, Qi Chen, Yun He, Kaiyan Liu, Xiaohui Zhang
Journal: Blood (2023)
Hematopoietic Stem/Progenitor Cell Intrinsic SAM Synthesis Is Required to Prevent p53 Pathway Activation By Maintaining DNA Stability
Authors: Eijiro Furukawa, Hiroki Kato, Sayaka Sano, Yan Yan, Daigo Michimata, Yuya Tanaka, Kazuki Sakurai, Koichi Onodera, Satoshi Ichikawa, Noriko Fukuhara, Yasushi Onishi, Hisayuki Yokoyama, Daisuke Saigusa, Tohru Fujiwara, Kazuhiko Igarashi, Hideo Harigae
Journal: Blood (2023)
Multiparametric Flow Cytometry-MRD Assay: Lesson from Phase II Trail REL AML 001
Authors: Arianna Gatti, Silvio Veronese, Giovanni Grillo, Barbara Di Camillo, Monica Fumagalli, Mauro Krampera, Patrizia Zappasodi, Erika Borlenghi, Elisabetta Todisco, Marta Ubezio, Massimo Bernardi, Alfredo Molteni, Claudia Basilico, Mauro Turrini, Rosa Greco, Valentina Mancini, Marta Riva, Gabriele Magliano, Marta Rachele Stefanucci, Bruno Brando, Alessandro Beghini, Roberto Cairoli
Journal: Blood (2023)
Survival and CNS Relapse in Patients with CD5-Positive Diffuse Large B-Cell Lymphoma: A Multi-Institutional Observational Study in Japan
Authors: Yuma Nato, Kana Miyazaki, Dai Maruyama, Hiroyuki Takahashi, Kazutaka Sunami, Satsuki Murakami, Eiju Negoro, Yuri Miyazawa, Ilseung Choi, Takahiro Okada, Nobuyuki Takayama, Naoto Tomita, Shuji Momose, Yuto Kaneda, Masahiro Yoshida, Hiroshi Gomyo, Kohtaro Toyama, Momoko Nishikori, Akio Saito, Junji Hiraga, Taro Masunari, Naoki Takahashi, Junya Makiyama, Tomotaka Suzuki, Hiroko Tsunemine, Jun Takizawa, Takeharu Kato, Yasufumi Masaki, Noriko Fukuhara, Masataka Okamoto, Isao Tawara, Naoko Asano, Koichi Ohshima, Koji Izutsu, Koji Kato, Ritsuro Suzuki, Motoko Yamaguchi
Journal: Blood (2023)
Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide Expedites Donor-Derived Immune Reconstitution in a Pediatric Severe Aplastic Anemia Cohort
Authors: Marketa Dimitrov, Svatava Merkle, Qing Cao, Meera Srikanthan, Christen L. Ebens
Journal: Blood (2023)
Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension and Weight Loss
Authors: Irina Shishkina, Danielle Bradshaw, Gita Giddens, Courtney Corley, Kimberly Green, Rachel Ashley, Sarah Jimenez, Locke Johnson Bryan, Ayushi Chauhan, Amany R. Keruakous, Molly Denlinger, Mohammad Mian, Ravindra Kolhe, Vamsi K. Kota, Anand Jillella
Journal: Blood (2023)
Retrospective Review of Patients Treated with Intrathecal Rituximab for Primary and Secondary CNS Lymphoma and Leukemia
Authors: Tatyana Feldman, Alexandra Della Pia, Geeny Lee, Thomas S. Gunning, Michael Pelliccia, Tony Varughese, Harsh Parmar, Andrew Ip, Lori A. Leslie, Andre Goy, Samuel Singer
Journal: Blood (2023)
Single-Cell RNA Sequencing Identifies Distinct Immune Microenvironment in Patients with Primary Plasma Cell Leukemia
Authors: Hyunsoo Cho, Haerim Chung, Jin Seok Kim, Mihee Kim, Ga-Young Song, Seo-Yeon Ahn, Deok-Hwan Yang, Hyeoung-Joon Kim, Je-Jung Lee, Jae-Sook Ahn, Sung-Hoon Jung
Journal: Blood (2023)
Patterns of Graft-Versus-Host Disease (GvHD) Prevention and Management in the Eastern Mediterranean (EM) Region: A Worldwide Network for Blood &amp; Marrow Transplantation (WBMT) Survey
Authors: Ibrahim Muhsen, Dietger Niederwieser, Laurent Garderet, Olaf Penack, Hildegard T. Greinix, Nour Ben Abdeljelil, Ibraheem Abosoudah, Sameer Alamoudi, Amal Albeihany, Saad Ahmed Al Daama, Mohammad Hamad Alshahrani, Salem Alshemmari, Murtadha Al-Khabori, Ahlam Almasari, Abdulhakim Al Rawas, Medhat Askar, Ali Bazarbachi, Mohammed-Amine Bekadja, Malek Benakli, Munira Borhany, Maria El kababri, Khaled Halahleh, Amir Ali Hamidieh, Mahmoud Hammad, Ahmad Ibrahim, Solaf Kanfar, Mohamed Hamed Khalaf, Mohammed Marei, Muhammad Ayaz Mir, Dania Monagel, Asma Quessar, Rawad Rihani, Munira Shabbir-Moosajee, Marwan Shaheen, Almetwaly Mohamed Sultan, Mohammad Vaezi, Mickey Boon Chai Koh, Zina Peric, Yoshiko Atsuta, Mahmoud Aljurf
Journal: Blood (2023)
Chidamide Combined with a Modified Bu-Cy Conditioning Regimen Improves Survival in Patients with T-Cell Acute Lymphoblastic Leukemia/Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Xuanqi Cao, Zheng Li, Yanming Zhang, Qingya Cui, Yunju Ma, Mengyun Li, Sifan Chen, Jia Yin, Wei Cui, Jia Chen, Aining Sun, Huiying Qiu, Suning Chen, Zhengming Jin, Xiaming Zhu, De-Pei Wu, Xiaowen Tang
Journal: Blood (2023)
Early Elevation of Absolute Eosinophil Count after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Chronic Graft-Versus-Host Disease in Children
Authors: Suguru Uemura, Kenji Kishimoto, Tomoko Fujikawa, Sayaka Hyodo, Aiko Kozaki, Atsuro Saito, Toshiaki Ishida, Takeshi Mori, Daiichiro Hasegawa, Yoshiyuki Kosaka
Journal: Blood (2023)
Evaluation of Bleeding Self-Assessments By Patients with Immune Thrombocytopenia (ITP): An Agreement Study
Authors: Bianca Clerici, Ngan Tang, Madison Cranstone, Yang Liu, Milena Hadzi-Tosev, Joanne Nixon, Melanie St John, Maryam Shirinzadeh, Erin Jamula, John G. Kelton, Donald Arnold
Journal: Blood (2023)
Myelodysplastic Syndrome Associated Hemophagocytic Lymphohistiocytosis: A Retrospective Study of 15 Cases in a Single Center
Authors: Yue Song, Fei Zhou, Xiaoli Li, Ziyan Wang, Liyun Bai, Yifang Yao, Limin Liu, Xiao Ma, Suning Chen, Depei Wu, Xuefeng He
Journal: Blood (2023)
Characteristics and Outcomes of Patients Receiving Sequential Bruton's Tyrosine Kinase Inhibitor (BTKi)/B-Cell Lymphoma 2 Inhibitor (BCL2i) for Treatment of Chronic Lymphocytic Leukemia (CLL) in the Real-World (rw) Practice Setting
Authors: Matthew S. Davids, Jacob Ambrose, Enrico De Nigris, Jennifer Prescott, Siyang Leng, Mohammed Z.H. Farooqui, Shravanthi R. Gandra, Christina M. Zettler, Laura L. Fernandes, Ching-Kun Wang, Mazyar Shadman
Journal: Blood (2023)
Hematological Response to Frontline Treatment in Lower Risk Myelodysplastic Syndromes (LRMDS) Is Associated with Better Overall Survival
Authors: Rami S. Komrokji, Muhammad Ammad-ud-din, Najla H Al Ali, Zhuoer Xie, Onyee Chan, Andrew T. Kuykendall, Seongseok Yun, Alison R. Walker, Jeffrey Lancet, Eric Padron, David A Sallman
Journal: Blood (2023)
A Proposal for a Classification of Ccus, MDS and AML Primarily Based on Genetic Abnormalities Considering the Biological Continuum of These Entities
Authors: Claudia Haferlach, Sandra Huber, Constance Regina Baer, Stephan Hutter, Manja Meggendorfer, Wolfgang Kern, Gregor Hoermann, Torsten Haferlach
Journal: Blood (2023)
Preliminary Safety and Efficacy of Emavusertib (CA-4948) in Acute Myeloid Leukemia Patients with <i>FLT3</i> Mutation
Authors: Eric S. Winer, Amit Verma, Stefanie Groepper, Katharina S. S. Götze, Yasmin Abaza, Christoph Schliemann, Gaurav S Choudhary, Wanying Zhao, Cole Gallagher, Reinhard von Roemeling, Daniel J. DeAngelo
Journal: Blood (2023)
Results from a Phase (Ph) 1 Clinical Study of the All-Oral Regimen of CC-486 and Venetoclax for Relapsed and Refractory Acute Myeloid Leukemia
Authors: Maria L Amaya, Christine M. McMahon, Marc Schwartz, Jonathan A Gutman, Connor Sohalski, Jennifer Tobin, Austin E Gillen, Anagha Inguva Sheth, Brett M Stevens, Clayton Smith, Craig T. Jordan, Daniel A. Pollyea
Journal: Blood (2023)
CD47 Blockade Enhances Phagocytic Activity of the TCR-Mimic Antibody Hu8F4 Against HLA-A2+ AML
Authors: Anna Sergeeva, Hong He, Lisa St. John, Ling Yu, Rong Cai, Kathryn Ruissard, Karen Clise-Dwyer, Rolando Vedia, Dan Li, Qing Ma, Celine Kerros, Mithil Chokshi, Vanshika Jhonsa, Gang Bao, Gheath Alatrash, Jeffrey J. Molldrem
Journal: Blood (2023)
Neurocognitive Outcomes over the First 3 Months after Chimeric Antigen Receptor T-Cell (CAR T) Therapy: Preliminary Findings from a Longitudinal Study
Authors: Samantha J Mayo, Kim Edelstein, Lori Bernstein, Tiana Coley, Stacey Morrison, Abi Vijenthira, Manjula Maganti, John Kuruvilla, Michael Crump, Sita D. Bhella, Robert Kridel, Vishal Kukreti, Chloe Yang, Shabbir MH Alibhai, Christine Chen, Anca Prica
Journal: Blood (2023)
Inhibiting FOXM1 Sensitizes Myeloma Cells to BCL2 Inhibitor Venetoclax By Repressing MYC Pathway
Authors: Vivian Zhou, Luke Moat, Manya Yu, Deepak Parashar, Abdul Shour, Liang Zhang, Terrie Kitchner, Sanjay Shukla, Song Guo, Gene Ananiev, Benita S. Katzenellenbogen, John Katzenellenbogen, Adedayo Onitilo, Siegfried Janz, Zhi Wen
Journal: Blood (2023)
Coagulation in Patients with Immune Thrombocytopenia and Other Associated Autoimmune Disorders
Authors: Nora Butta, Elena Monzón Manzano, Paula Acuña, Elena G Arias-Salgado, Maria Isabel Rivas Pollmar, Monica Martin Salces, Ana Mendoza-Martínez, Víctor Jiménez-Yuste, Waleed Ghanima, Maria Teresa Álvarez-Roman
Journal: Blood (2023)
Tumor Suppressive Mir-7 Targeting <i>PSME3</i> Improves the Efficacy of Histone Deacetylases Inhibitors in Multiple Myeloma
Authors: Masahiro Yamada, Sho Ikeda, Wataru Kuroki, Sayaka Iwama, Yuto Takahashi, Akihiro Kitadate, Fumito Abe, Hiroyuki Tagawa, Naoto Takahashi
Journal: Blood (2023)
The Variable Heavy Chain Antibody Syn-VWFA1 Inhibits the Interaction of Platelets to Von Willebrand Factor in Solution but Not to Immobilized Von Willebrand Factor Thereby Inhibiting 3-Dimensional but Not 2-Dimensional Thrombus Formation
Authors: Dana Huskens, Lisa Nynke Van Der Vorm, Joke Konings, Nicholas Arce, Mark Roest, Philip G. De Groot, Renhao Li, Jasper A. Remijn, Bas De Laat
Journal: Blood (2023)
The Diversity of FLT3-ITD and the Prognostic Impact in Adult Acute Myeloid Leukemia
Authors: Jingyi Yang, Shanlan Mo, Xudong Wei, Xiaodong Lv, Baijun Fang, Yanli Zhang, Jian Zhou, Hu Zhou, Yuewen Fu, Quande Lin, Delong Liu, Yongping Song, Qianfei Wang, Keshu Zhou
Journal: Blood (2023)
Multi-source multi-modal markers for Bayesian Networks: Application to the extremely preterm born brain
Authors: Hassna Irzan, Michael Hütel, Helen O’Reilly, Sebastien Ourselin, Neil Marlow, Andrew Melbourne
Journal: Medical Image Analysis (2023)

The preterm phenotype results from the interplay of multiple disorders affecting the brain and cognitive outcomes. Accurately characterising these interactions can reveal prematurity markers. Bayesian Networks (BNs) are powerful tools to disentangle these relationships, as they inherently measure associations between variables while mitigating confounding factors. We present Modified PC-HC (MPC-HC), a Bayesian Network (BN) structural learning algorithm. MPC-HC employs statistical testing and search-and-score techniques to explore equivalent classes. We employ MPC-HC to estimate BNs for extremely preterm (EP) young adults and full-term controls. Using MRI measurements and cognitive performance markers, we investigate predictive relationships and mutual influences through predictions and sensitivity analysis. We assess the confidence in the estimated BN structures using bootstrapping. Furthermore, MPC-HC's validation involves assessing its ability to recover benchmark BN structures. MPC-HC achieves an average prediction accuracy of 72.5% compared to 62.5% of PC, 64.5% of MMHC, and 71.5% of HC, while it outperforms PC, MMHC, and HC algorithms in reconstructing the true structure of benchmark BNs. The sensitivity analysis shows that MRI measurements mainly affect EP cognitive scores. Our work has two key contributions: first, the introduction and validation of a new BN structure learning method. Second, demonstrating the potential of BNs in modelling variable relationships, predicting variables of interest, modelling uncertainty, and evaluating how variables impact each other. Finally, we demonstrate this by characterising complex phenotypes, such as preterm birth, and discovering results consistent with literature findings.
Prevention of Ocular Toxicity Using Protective Contact Lenses in Multiple Myeloma Patients Receiving Belantamab Mafodotin, Pomalidomide and Dexamethasone: A Sub-Study of the Cmrg-007 Trial
Authors: Martha L Louzada, Donna E. Reece, Arleigh McCurdy, Rami Kotb, Ibraheem Othman, Hira Mian, Toni Lin, Michael P Chu, Darrell White, Stephen Parkin, Engin Gul, Aniba Khan, Suzanne Trudel
Journal: Blood (2023)
<i>In Vitro and In Vivo</i> Specificity and Biodistribution of a Novel CD8-Targeted Fusosome
Authors: Hemantkumar Chavan, Shirisha Amatya, Valeria Berlfein, Patricia Cruite, Vandana Chaturvedi, Vasily Vagin, Neal van Hoeven, Jagesh Shah, Terry J. Fry, Boris Gorovits, Sundeep Chandra
Journal: Blood (2023)
A Phase 4, Observational Study Evaluating the Efficacy and Safety of the Bruton Tyrosine Kinase Inhibitor (BTKi) Zanubrutinib in Patients with Waldenström Macroglobulinemia (WM)
Authors: Edwin C. Kingsley, Shannon Fabre, Motohisa Takai, Aileen Cleary Cohen, Jingjing Schneider, Jessica Li, James D'Olimpio
Journal: Blood (2023)
Updated Results from a Phase II Study of Hyper-CVAD, with or without Inotuzumab Ozogamicin, and Sequential Blinatumomab in Patients with Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia
Authors: Daniel Nguyen, Hagop M. Kantarjian, Nicholas J. Short, Nitin Jain, Fadi G. Haddad, Musa Yilmaz, Alessandra Ferrajoli, Tapan M. Kadia, Yesid Alvarado Valero, Abhishek Maiti, Cedric Nasnas, Lewis Nasr, Rebecca Garris, Marina Y. Konopleva, Farhad Ravandi, Elias Jabbour
Journal: Blood (2023)
High Deletion Burden Identified By Whole Genome Sequencing Is Associated with Enhanced Risk in del17p CLL Patients
Authors: Preeti Trisal, Esteban Braggio, Nicholas Stong, Kay L. Medina, Sameer A. Parikh, Daniel L. Van Dyke, Kari G. Rabe, Zhiquan Wang, C. Chris Huang, Anita K. Gandhi, Neil E. Kay
Journal: Blood (2023)
Genomic and Immune Determinants of Resistance to Anti-CD38 MoAb Based Therapy in Relapsed Multiple Myeloma
Authors: Bachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, Giuseppe Bertuglia, Elona Saraci, Stefania Oliva, Benjamin Diamond, Niccolò Bolli, Paolo Corradini, David Coffey, Ola Landgren, Benedetto Bruno, Mario Boccadoro, Massimo Massaia, Francesco Maura, Alessandra Larocca
Journal: Blood (2023)
Venetoclax Combined with Azacitidine Was Effective and Safe for Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma: Preliminary Results of a Phase 2, Multicenter Trial
Authors: Han-Yu Cao, Lu-Lu Chen, Chao-Ling Wan, Xiao-Hui Hu, Bing Wu, Li Yang, Li Wang, Yang Zhang, De-Pei Wu, Hai-Ping Dai, Hao Zhang, Shengli Xue
Journal: Blood (2023)
Evaluation of a Novel Method for the Assessment of Ocular Adverse Events and Associated Functional Impact in Transplant Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Belantamab Mafodotin, Lenalidomide, and Dexamethasone in the Phase 1/2 Belard Trial
Authors: Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Vasiliki Spiliopoulou, Rodanthi Syrigou, Evangelos Eleutherakis-Papaiakovou, Maria Douvali, Stavros Gkolfinopoulos, Efstathios Kastritis, Meletios A. Dimopoulos
Journal: Blood (2023)
Preliminary Results of Phase 2 Open Label Study of Lorlatinib Monotherapy in Relapsed/Refractory ALK + Lymphomas Previously Treated with Other Tyrosine Kinase Inhibitors
Authors: Alessia Ripamonti, Andrea Aroldi, Federica Cocito, Luca Guerra, Lavinia Monaco, Bianca Maria Granelli, Lara Mussolin, Carlo Gambacorti-Passerini
Journal: Blood (2023)
Preconditioning Single High-Dose Palifermin Alters the Posttransplant Inflammatory Cytokine Profile
Authors: Eduard Schulz, Noa G. Holtzman, Alen Ostojic, Filip Pirsl, Seth M. Steinberg, Lauren M. Curtis, Brian C. Shaffer, Theo Heller, Ashley Carpenter, Frances T. Hakim, Jeffrey S. Rubin, Steven Z. Pavletic
Journal: Blood (2023)
Cytokine Release Syndrome and Neurological Event Management Resource Use and Costs Among Patients with Relapsed or Refractory Large B-Cell Lymphoma Who Received Second-Line Lisocabtagene Maraleucel Treatment in TRANSFORM and PILOT
Authors: November McGarvey, Matthew Gitlin, Abraham Lee, Scott J. Keating, Victoria Barghout, Simran K. Tiwana
Journal: Blood (2023)
A Novel Composite Endpoint of Toxicity-Free, Progression-Free Survival (TPFS) after CD19-Directed Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma
Authors: Aditi Saha, Razan Mohty, Junmin Whiting, Kristen Flores, Jongphil Kim, Taiga Nishihori, Julio C Chavez, Farhad Khimani, Doris K. Hansen, Fabiana Perna, Hien Liu, Bijal D. Shah, Marian Dam, Muhammad Jaffer, Sepideh Mokhtari, Hany Elmariah, Rawan Faramand, Christina A Bachmeier, Nelli Bejanyan, Frederick L. Locke, Michael D. Jain, Aleksandr Lazaryan
Journal: Blood (2023)
High-Throughput Identification of Graft-Vs-Leukemia TCRs in AML Patient Samples after Allogeneic Stem Cell Transplantation
Authors: Noah J Tubo, Duncheng Wang, Qiuming He, Yibin Chen, Ho Ngai, Yanqing Huang, Celine Kerros, Xizeng Mao, Shoudan Liang, Sachet Shukla, Arnau Peris Cuesta, Pavan Bachireddy, Julio Alcantara Montiel, Gheath Alatrash, Priya Koppikar, Jeffrey J. Molldrem
Journal: Blood (2023)
Risk Factors for Thrombosis in Essential Thrombocythemia: A Clinico-Pathological Study of 138 Patents in a Middle Eastern Population
Authors: Aamer Aleem, Abdullah Alqahtani, Leena Alshaman, Nawaf Aldawsari, Farjah Algahtani, Ahmed Jamal, Zafar Iqbal, Musa Alzahrani, Khalid AlSaleh, Sarah Sewaralthahab, Fatimah Alshalati, Naif Saud Albudayri, Ghazi S Alotaibi
Journal: Blood (2023)
Cognitive functioning in untreated glioma patients: The limited predictive value of clinical variables
Authors: Sander M Boelders, Karin Gehring, Eric O Postma, Geert-Jan M Rutten, Lee-Ling S Ong
Journal: Neuro-Oncology (2023)

Abstract Background Previous research identified many clinical variables that are significantly related to cognitive functioning before surgery. It is not clear whether such variables enable accurate prediction for individual patients’ cognitive functioning because statistical significance does not guarantee predictive value. Previous studies did not test how well cognitive functioning can be predicted for (yet) untested patients. Furthermore, previous research is limited in that only linear or rank-based methods with small numbers of variables were used. Methods We used various machine learning models to predict preoperative cognitive functioning for 340 patients with glioma across 18 outcome measures. Predictions were made using a comprehensive set of clinical variables as identified from the literature. Model performances and optimized hyperparameters were interpreted. Moreover, Shapley additive explanations were calculated to determine variable importance and explore interaction effects. Results Best-performing models generally demonstrated above-random performance. Performance, however, was unreliable for 14 out of 18 outcome measures with predictions worse than baseline models for a substantial number of train-test splits. Best-performing models were relatively simple and used most variables for prediction while not relying strongly on any variable. Conclusions Preoperative cognitive functioning could not be reliably predicted across cognitive tests using the comprehensive set of clinical variables included in the current study. Our results show that a holistic view of an individual patient likely is necessary to explain differences in cognitive functioning. Moreover, they emphasize the need to collect larger cross-center and multimodal data sets.
Patterns of Response to 200 Mg Linvoseltamab in Patients with Relapsed/Refractory Multiple Myeloma: Longer Follow-Up of the Linker-MM1 Study
Authors: Sundar Jagannath, Joshua Richter, Madhav V. Dhodapkar, James E. Hoffman, Hans C. Lee, Attaya Suvannasankha, Mansi R. Shah, Suzanne Lentzsch, Jeffrey A. Zonder, Rachid Baz, Joseph J. Maly, Swathi Namburi, Ka Lung Wu, Matthew Pianko, Jing Christine Ye, Rebecca Silbermann, Chang-Ki Min, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquín Martínez Lopez, Michelle DeVeaux, Dhruti Chokshi, Anita Boyapati, Anasuya Hazra, Karen Rodriguez Lorenc, Glenn S. Kroog, Yariv Houvras, Naresh Bumma
Journal: Blood (2023)
Cost-Effectiveness of Axicabtagene Ciloleucel Versus Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma in the US
Authors: Olalekan O. Oluwole, Markqayne D Ray, Richard Zur, Aurelia Little, Cheryl Ferrufino, Brett Doble, Anik R Patel, Pinar Bilir
Journal: Blood (2023)
Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers
Authors: Jing Sun, Jia Luo, Fangyuan Jiang, Jianhui Zhao, Siyun Zhou, Lijuan Wang, Dongfeng Zhang, Yuan Ding, Xue Li
Journal: JNCI Journal of the National Cancer Institute (2023)

The proteome is an important reservoir of potential therapeutic targets for cancer. This study aimed to examine the causal associations between plasma proteins and cancer risk and to identify proteins with cross-cancer effects.
Comparing Cairo Bishop and Howard Criteria for Identifying Clinically Meaningful Tumor Lysis Syndrome Among Acute Myeloid Leukemia Patients Treated with Venetoclax and Hypomethylating Agents: A Single Center Experience
Authors: Margaret Rowe, Daria V Babushok, Martin Carroll, Alison Carulli, Noelle V. Frey, Saar Gill, Elizabeth O Hexner, Rebecca Hirsh, Nasheed Hossain, Catherine Lai, Alison W Loren, Selina M Luger, Ivan Maillard, Shannon R McCurdy, Andrew H Matthews, Mary Ellen Martin, Vikram R Paralkar, Alexander Perl, David L. Porter, Keith W Pratz, Edward A. Stadtmauer, Ximena Jordan Bruno
Journal: Blood (2023)
Usefulness of Peripheral Blood Samples in Diagnosis and Prognosis Assessment of Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia Low Risk Patients Using Next Generation Sequencing
Authors: Pamela Acha, Ana Manzanares, Blanca Xicoy, Lurdes Zamora, Cristina de la Fuente, Marta Julià, Martin Mascaro Riera, Joan Bargay, Alfonso García, Maria Julia Montoro, Laura Palomo, Helena Pomares, Montserrat Arnan Sangerman, Francisco Fuster-Tormo, Mar Mallo, Oriol Calvete, Julia Mestre, Isabel Granada, Mercedes Berenguer, Francesc Sole
Journal: Blood (2023)
Double-Blind Randomized Study to Evaluate the Effect of Hydroxycarbamide on Albuminuria in Adults with Sickle Cell Disease: Sikamic (SIklos on Kidney Function and AlbuMInuria Clinical Trial)
Authors: Saliou Diop, Aldiouma Guindo, Gonzalo De Luna, Aurélien Yapi, Giovanna Cannas, Maryse Etienne-Julan, Jean-Benoit Arlet, Stephanie Ngo, Emmanuelle Bernit, Justine Gellen-Dautremer, Gylna Loko, Stanislas Nimubona, Anoosha Habibi, Vincent Audard, Pablo Bartolucci
Journal: Blood (2023)
Excellent Outcome Following Maintenance Therapy with Gilteritinib after Allogeneic Hematopoietic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia Even in Non-Remission Status
Authors: Aya Nishida, Otoya Watanabe, Daisuke Kaji, Yuki Taya, Shinsuke Takagi, Hisashi Yamamoto, Go Yamamoto, Yuki Asano-Mori, Atsushi Wake, Naoyuki Uchida
Journal: Blood (2023)
Clinical, Cytogenetic and Molecular Characterization of a 96 MDS and AML Cohort with <i>TP53</i> Mutation
Authors: Marine Duranjou, Cécile Castoldi, Anne Sophie Alary, Yosr Hicheri, Colombe Saillard, Camille Rouzaud, Aude Charbonnier, Bilal Mohty, Evelyne D'Incan, Jerome Rey, Marie Anne Hospital, Raynier Devillier, Norbert Vey, Véronique Gelsi-Boyer, Anne-Catherine Lhoumeau, Anne Murati, Florence Golesi, Marie Joelle Mozziconacci, Antoine Ittel, Sylvain Garciaz
Journal: Blood (2023)
Olverembatinib(HQP1351)-Based Therapy in Adults with Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Advanced Chronic Myeloid Leukemia: Results of the Real-Life Study
Authors: Ziyu Wen, Zhiping Fan, Qiang Wang, Xuan Zhou, Zherou He, Zicheng Gao, Hong Chen, Hanyin Liang, Dongmei Luo, Xiaoli Liu, Hongsheng Zhou, Qifa Liu, Na Xu
Journal: Blood (2023)